Skip to main content

Table 1 Patient Characteristics at Baseline, by Pulmonary Exacerbations During Study

From: Impact of pulmonary exacerbations and lung function on generic health-related quality of life in patients with cystic fibrosis

 

No PE

Any PE

PE (No Hospitalization)

PE (Hospitalization)

(n = 89)

(n = 72)

(n = 38)

(n = 34)

Age, Mean (SD)

25.5 (10.2)

25.4 (8.8)

28.3 (7.8)

22.0 (8.7)

Female, N(%)

41 (46.1 %)

43 (59.7 %)

20 (52.6 %)

23 (67.6 %)

ppFEV1, Mean (SD)

65.8 (15.8)

60.8 (16.9)

60.9 (16.3)

60.6 (17.7)

BMI, N(%)

    

 Normal Weight

75 (84.3 %)

57 (79.2 %)

28 (73.7 %)

29 (85.3 %)

 Obese

3 (3.4 %)

2 (2.8 %)

2 (5.3 %)

0 (0 %)

 Overweight

9 (10.1 %)

8 (11.1 %)

6 (15.8 %)

2 (5.9 %)

 Underweight

2 (2.3 %)

5 (6.9 %)

2 (5.3 %)

3 (8.8 %)

Sweat chloride, Mean (SD)

100.5 (9.5)

99.9 (11.3)

100 (11.4)

99.8 (11.2)

History of pancreatic insufficiency, N(%)

81 (91.0 %)

68 (94.4 %)

35 (92.1 %)

33 (97.1 %)

Use of inhaled cycling antibiotic, N(%)

37 (41.6)

19 (26.4 %)

8 (21.1 %)

11 (32.4 %)